Industry: Medical Devices & Consumables
Published Date: 2025-02-07
Pages: 185 Pages
Report ld: 3427416
Request Sample
Customized Report
Lab Automation in Proteomics Market Size(US$)

CAGR 2025-2031
6.4%
Market Size,2031
USD 4,269
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
The global key players of lab automation in proteomics include Thermo Fisher, Beckman Coulter (Danaher), Agilent Technologies, PerkinElmer, Roche, Siemens Healthineers, BD, and Waters, etc. The global top 8 players hold a share over 60%. North America is the largest producer, has a share about 50%, followed by Europe, with a share about 30%. In terms of product type, analytical automation segment occupies for over 60%, while in terms of end users, biotechnology and pharmaceutical companies are the largest segment, with a share over 40%.
This report aims to provide a comprehensive presentation of the global market for Lab Automation in Proteomics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lab Automation in Proteomics by region & country, by Type, and by Application.
The Lab Automation in Proteomics market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lab Automation in Proteomics.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lab Automation in Proteomics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lab Automation in Proteomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lab Automation in Proteomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Lab Automation in Proteomics Product Introduction
1.2 Global Lab Automation in Proteomics Market Size Forecast
1.2.1 Global Lab Automation in Proteomics Sales Value (2020-2031)
1.2.2 Global Lab Automation in Proteomics Sales Volume (2020-2031)
1.2.3 Global Lab Automation in Proteomics Sales Price (2020-2031)
1.3 Lab Automation in Proteomics Market Trends & Drivers
1.3.1 Lab Automation in Proteomics Industry Trends
1.3.2 Lab Automation in Proteomics Market Drivers & Opportunity
1.3.3 Lab Automation in Proteomics Market Challenges
1.3.4 Lab Automation in Proteomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lab Automation in Proteomics Players Revenue Ranking (2024)
2.2 Global Lab Automation in Proteomics Revenue by Company (2020-2025)
2.3 Global Lab Automation in Proteomics Players Sales Volume Ranking (2024)
2.4 Global Lab Automation in Proteomics Sales Volume by Company Players (2020-2025)
2.5 Global Lab Automation in Proteomics Average Price by Company (2020-2025)
2.6 Key Manufacturers Lab Automation in Proteomics Manufacturing Base and Headquarters
2.7 Key Manufacturers Lab Automation in Proteomics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lab Automation in Proteomics
2.9 Lab Automation in Proteomics Market Competitive Analysis
2.9.1 Lab Automation in Proteomics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Lab Automation in Proteomics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lab Automation in Proteomics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pre-analytical Automation
3.1.2 Analytical Automation
3.1.3 Post-analytical Automation
3.1.4 Total Lab Automation
3.2 Global Lab Automation in Proteomics Sales Value by Type
3.2.1 Global Lab Automation in Proteomics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Lab Automation in Proteomics Sales Value, by Type (2020-2031)
3.2.3 Global Lab Automation in Proteomics Sales Value, by Type (%) (2020-2031)
3.3 Global Lab Automation in Proteomics Sales Volume by Type
3.3.1 Global Lab Automation in Proteomics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Lab Automation in Proteomics Sales Volume, by Type (2020-2031)
3.3.3 Global Lab Automation in Proteomics Sales Volume, by Type (%) (2020-2031)
3.4 Global Lab Automation in Proteomics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology and Pharmaceutical Companies
4.1.2 Hospitals and Diagnostic Laboratories
4.1.3 Research and Academic Institutes
4.1.4 Others
4.2 Global Lab Automation in Proteomics Sales Value by Application
4.2.1 Global Lab Automation in Proteomics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Lab Automation in Proteomics Sales Value, by Application (2020-2031)
4.2.3 Global Lab Automation in Proteomics Sales Value, by Application (%) (2020-2031)
4.3 Global Lab Automation in Proteomics Sales Volume by Application
4.3.1 Global Lab Automation in Proteomics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Lab Automation in Proteomics Sales Volume, by Application (2020-2031)
4.3.3 Global Lab Automation in Proteomics Sales Volume, by Application (%) (2020-2031)
4.4 Global Lab Automation in Proteomics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Lab Automation in Proteomics Sales Value by Region
5.1.1 Global Lab Automation in Proteomics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Lab Automation in Proteomics Sales Value by Region (2020-2025)
5.1.3 Global Lab Automation in Proteomics Sales Value by Region (2026-2031)
5.1.4 Global Lab Automation in Proteomics Sales Value by Region (%), (2020-2031)
5.2 Global Lab Automation in Proteomics Sales Volume by Region
5.2.1 Global Lab Automation in Proteomics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Lab Automation in Proteomics Sales Volume by Region (2020-2025)
5.2.3 Global Lab Automation in Proteomics Sales Volume by Region (2026-2031)
5.2.4 Global Lab Automation in Proteomics Sales Volume by Region (%), (2020-2031)
5.3 Global Lab Automation in Proteomics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Lab Automation in Proteomics Sales Value, 2020-2031
5.4.2 North America Lab Automation in Proteomics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Lab Automation in Proteomics Sales Value, 2020-2031
5.5.2 Europe Lab Automation in Proteomics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Lab Automation in Proteomics Sales Value, 2020-2031
5.6.2 Asia Pacific Lab Automation in Proteomics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Lab Automation in Proteomics Sales Value, 2020-2031
5.7.2 South America Lab Automation in Proteomics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lab Automation in Proteomics Sales Value, 2020-2031
5.8.2 Middle East & Africa Lab Automation in Proteomics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lab Automation in Proteomics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Lab Automation in Proteomics Sales Value
6.2.1 Key Countries/Regions Lab Automation in Proteomics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Lab Automation in Proteomics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Lab Automation in Proteomics Sales Value, 2020-2031
6.3.2 United States Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Lab Automation in Proteomics Sales Value, 2020-2031
6.4.2 Europe Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Lab Automation in Proteomics Sales Value, 2020-2031
6.5.2 China Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Lab Automation in Proteomics Sales Value, 2020-2031
6.6.2 Japan Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Lab Automation in Proteomics Sales Value, 2020-2031
6.7.2 South Korea Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Lab Automation in Proteomics Sales Value, 2020-2031
6.8.2 Southeast Asia Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Lab Automation in Proteomics Sales Value, 2020-2031
6.9.2 India Lab Automation in Proteomics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Lab Automation in Proteomics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Introduction and Business Overview
7.1.3 Thermo Fisher Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Lab Automation in Proteomics Product Offerings
7.1.5 Thermo Fisher Recent Development
7.2 Beckman Coulter (Danaher)
7.2.1 Beckman Coulter (Danaher) Company Information
7.2.2 Beckman Coulter (Danaher) Introduction and Business Overview
7.2.3 Beckman Coulter (Danaher) Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Beckman Coulter (Danaher) Lab Automation in Proteomics Product Offerings
7.2.5 Beckman Coulter (Danaher) Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Information
7.3.2 Agilent Technologies Introduction and Business Overview
7.3.3 Agilent Technologies Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Agilent Technologies Lab Automation in Proteomics Product Offerings
7.3.5 Agilent Technologies Recent Development
7.4 PerkinElmer
7.4.1 PerkinElmer Company Information
7.4.2 PerkinElmer Introduction and Business Overview
7.4.3 PerkinElmer Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 PerkinElmer Lab Automation in Proteomics Product Offerings
7.4.5 PerkinElmer Recent Development
7.5 Roche
7.5.1 Roche Company Information
7.5.2 Roche Introduction and Business Overview
7.5.3 Roche Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Roche Lab Automation in Proteomics Product Offerings
7.5.5 Roche Recent Development
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Company Information
7.6.2 Siemens Healthineers Introduction and Business Overview
7.6.3 Siemens Healthineers Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Siemens Healthineers Lab Automation in Proteomics Product Offerings
7.6.5 Siemens Healthineers Recent Development
7.7 BD
7.7.1 BD Company Information
7.7.2 BD Introduction and Business Overview
7.7.3 BD Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 BD Lab Automation in Proteomics Product Offerings
7.7.5 BD Recent Development
7.8 Waters
7.8.1 Waters Company Information
7.8.2 Waters Introduction and Business Overview
7.8.3 Waters Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Waters Lab Automation in Proteomics Product Offerings
7.8.5 Waters Recent Development
7.9 Hudson Robotics
7.9.1 Hudson Robotics Company Information
7.9.2 Hudson Robotics Introduction and Business Overview
7.9.3 Hudson Robotics Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Hudson Robotics Lab Automation in Proteomics Product Offerings
7.9.5 Hudson Robotics Recent Development
7.10 Synchron
7.10.1 Synchron Company Information
7.10.2 Synchron Introduction and Business Overview
7.10.3 Synchron Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Synchron Lab Automation in Proteomics Product Offerings
7.10.5 Synchron Recent Development
7.11 Formulatrix
7.11.1 Formulatrix Company Information
7.11.2 Formulatrix Introduction and Business Overview
7.11.3 Formulatrix Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Formulatrix Lab Automation in Proteomics Product Offerings
7.11.5 Formulatrix Recent Development
7.12 Integra
7.12.1 Integra Company Information
7.12.2 Integra Introduction and Business Overview
7.12.3 Integra Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Integra Lab Automation in Proteomics Product Offerings
7.12.5 Integra Recent Development
7.13 BRAND
7.13.1 BRAND Company Information
7.13.2 BRAND Introduction and Business Overview
7.13.3 BRAND Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 BRAND Lab Automation in Proteomics Product Offerings
7.13.5 BRAND Recent Development
7.14 Bio-Rad
7.14.1 Bio-Rad Company Information
7.14.2 Bio-Rad Introduction and Business Overview
7.14.3 Bio-Rad Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Bio-Rad Lab Automation in Proteomics Product Offerings
7.14.5 Bio-Rad Recent Development
7.15 Shimadzu
7.15.1 Shimadzu Company Information
7.15.2 Shimadzu Introduction and Business Overview
7.15.3 Shimadzu Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Shimadzu Lab Automation in Proteomics Product Offerings
7.15.5 Shimadzu Recent Development
7.16 Bruker
7.16.1 Bruker Company Information
7.16.2 Bruker Introduction and Business Overview
7.16.3 Bruker Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Bruker Lab Automation in Proteomics Product Offerings
7.16.5 Bruker Recent Development
7.17 Tecan
7.17.1 Tecan Company Information
7.17.2 Tecan Introduction and Business Overview
7.17.3 Tecan Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Tecan Lab Automation in Proteomics Product Offerings
7.17.5 Tecan Recent Development
7.18 Eppendorf
7.18.1 Eppendorf Company Information
7.18.2 Eppendorf Introduction and Business Overview
7.18.3 Eppendorf Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Eppendorf Lab Automation in Proteomics Product Offerings
7.18.5 Eppendorf Recent Development
7.19 Analytic Jena
7.19.1 Analytic Jena Company Information
7.19.2 Analytic Jena Introduction and Business Overview
7.19.3 Analytic Jena Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Analytic Jena Lab Automation in Proteomics Product Offerings
7.19.5 Analytic Jena Recent Development
7.20 SPT Labtech
7.20.1 SPT Labtech Company Information
7.20.2 SPT Labtech Introduction and Business Overview
7.20.3 SPT Labtech Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 SPT Labtech Lab Automation in Proteomics Product Offerings
7.20.5 SPT Labtech Recent Development
7.21 Hamilton Company
7.21.1 Hamilton Company Company Information
7.21.2 Hamilton Company Introduction and Business Overview
7.21.3 Hamilton Company Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Hamilton Company Lab Automation in Proteomics Product Offerings
7.21.5 Hamilton Company Recent Development
7.22 Aurora Biomed
7.22.1 Aurora Biomed Company Information
7.22.2 Aurora Biomed Introduction and Business Overview
7.22.3 Aurora Biomed Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Aurora Biomed Lab Automation in Proteomics Product Offerings
7.22.5 Aurora Biomed Recent Development
7.23 Dynex Technologies
7.23.1 Dynex Technologies Company Information
7.23.2 Dynex Technologies Introduction and Business Overview
7.23.3 Dynex Technologies Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 Dynex Technologies Lab Automation in Proteomics Product Offerings
7.23.5 Dynex Technologies Recent Development
7.24 Abbott
7.24.1 Abbott Company Information
7.24.2 Abbott Introduction and Business Overview
7.24.3 Abbott Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 Abbott Lab Automation in Proteomics Product Offerings
7.24.5 Abbott Recent Development
7.25 Luminex Corporation
7.25.1 Luminex Corporation Company Information
7.25.2 Luminex Corporation Introduction and Business Overview
7.25.3 Luminex Corporation Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.25.4 Luminex Corporation Lab Automation in Proteomics Product Offerings
7.25.5 Luminex Corporation Recent Development
7.26 Shanghai Vanetterlab
7.26.1 Shanghai Vanetterlab Company Information
7.26.2 Shanghai Vanetterlab Introduction and Business Overview
7.26.3 Shanghai Vanetterlab Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2020-2025)
7.26.4 Shanghai Vanetterlab Lab Automation in Proteomics Product Offerings
7.26.5 Shanghai Vanetterlab Recent Development
8 Industry Chain Analysis
8.1 Lab Automation in Proteomics Industrial Chain
8.2 Lab Automation in Proteomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lab Automation in Proteomics Sales Model
8.5.2 Sales Channel
8.5.3 Lab Automation in Proteomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Lab Automation in Proteomics market size was US$ 2950 million in 2025 and is forecast to reach a readjusted size of US$ 4513 million by 2032 with a CAGR of 6.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 121
USD 4250.00
(Single User License)
The global Lab Automation in Proteomics market was valued at US$ 2950 million in 2025 and is anticipated to reach US$ 4513 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 156
USD 2900.00
(Single User License)
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2950 million in 2025 and is projected to reach US$ 4513 million, growing at a CAGR of 6.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 175
USD 3950.00
(Single User License)
The global Lab Automation in Proteomics market size was US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 125
USD 4250.00
(Single User License)
The global Lab Automation in Proteomics market is projected to grow from US$ 2791 million in 2024 to US$ 4269 million by 2031, at a CAGR of 6.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 211
USD 4900.00
(Single User License)
The global market for Lab Automation in Proteomics was valued at US$ 2791 million in the year 2024 and is projected to reach a revised size of US$ 4269 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Published Date: 2025-02-07
Pages: 120
USD 2900.00
(Single User License)
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published Date: 2024-01-18
Pages: 170
USD 3950.00
(Single User License)
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published Date: 2024-01-03
Pages: 107
USD 2900.00
(Single User License)
The global Lab Automation in Proteomics market size was US$ 2950 million in 2025 and is forecast to reach a readjusted size of US$ 4513 million by 2032 with a CAGR of 6.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 121
The global Lab Automation in Proteomics market was valued at US$ 2950 million in 2025 and is anticipated to reach US$ 4513 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 156
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2950 million in 2025 and is projected to reach US$ 4513 million, growing at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 175
The global Lab Automation in Proteomics market size was US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 125
The global Lab Automation in Proteomics market is projected to grow from US$ 2791 million in 2024 to US$ 4269 million by 2031, at a CAGR of 6.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 211
The global market for Lab Automation in Proteomics was valued at US$ 2791 million in the year 2024 and is projected to reach a revised size of US$ 4269 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Published: 2025-02-07
Pages: 120
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published: 2024-01-18
Pages: 170
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published: 2024-01-03
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now